Share on Facebook Tweet This

DAVID JUNKIN | WHAT’S BEHIND THE BIOTECH SECTOR’S REBOUND FOR THE WALL STREET JOURNAL

Here’s a great piece by DAVID JUNKIN for The Wall Street Journal! The article is called “What’s Behind the Biotech Sector’s Rebound: Biotech ETFs has investors’ hearts pumping again. Fund buying after Donald Trump’s election helped. The Nasdaq Biotechnology Index fell 21% in 2016 but is up 11% so far in 2017. ” Will risks remain? Huge thanks to Sheryl for a great assignment!

IF-AD117_BIOTEC_12U_20170530184319BIOTECH-2

Save

Save

Save


Posted on 06/05/2017 for DAVID JUNKIN

Tags: , , , , , , , , , ,